Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05459545 · ClinicalTrials.gov registry record
Real-World Evaluation of Eko Algorithms in a Point of Care Setting
A clinical trial, sponsored by Eko Devices.
- Completed
- Registry status
- 371
- Enrollment target
NCT05459545: Completed study, sponsored by Eko Devices.
NCT05459545 is a clinical trial that has completed, run by Eko Devices. The registered enrollment target is 371 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05459545 has completed, sponsored by Eko Devices.
- COMPLETED
- Registry status
- 371 participants
- Enrollment target
Study Summary
The purpose of this research is to prospectively test and validate the utility of Eko artificial intelligence (AI) plus Eko Murmur Analysis Software (EMAS) murmur characterization in algorithm in a real world, point-of-care setting.
Primary Outcome
Sensitivity and specificity of Eko's murmur detection algorithm relative to ground truth. Ground truth is defined as echocardiography-confirmed clinically-significant (graded "mild-to-moderate" or greater severity) VHD that is associated with a murmur, as confirmed by an expert panel.
Interventions
- DEVICE Use of Eko CORE and Eko CORE 500 electronic stethoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 371 participants |
| Start Date | 2022-04-15 |
| Est. Completion | 2023-06-30 |
What the finished NCT05459545 record still lists
NCT05459545 is an observational study that tracks outcomes without assigning an intervention. The registered 371 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Use of Eko CORE and Eko CORE 500 electronic stethoscope is the first listed.
NCT05459545 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05459545 about?
NCT05459545 is a clinical study titled "Real-World Evaluation of Eko Algorithms in a Point of Care Setting". The purpose of this research is to prospectively test and validate the utility of Eko artificial intelligence (AI) plus Eko Murmur Analysis Software (EMAS) murmur characterization in algorithm in a real world, point-of-care setting.
What is the current status of trial NCT05459545?
This trial is currently completed. The enrollment target is 371 participants. The study started on 2022-04-15. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05459545?
The interventions under investigation include: Use of Eko CORE and Eko CORE 500 electronic stethoscope (DEVICE).
Who is sponsoring clinical trial NCT05459545?
This trial is sponsored by Eko Devices, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05743673 · 371 participants
SHAPE Test for Preoperative Risk Stratification
- NCT05761847 · 371 participants · NA
Pediatric Medication Therapy Management Trial
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI